{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:11:59Z","timestamp":1791425519725,"version":"4.3.3"},"reference-count":34,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2012,9,17]],"date-time":"2012-09-17T00:00:00Z","timestamp":1347840000000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J American Geriatrics Society"],"published-print":{"date-parts":[[2012,9]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>\n                      To review data from randomized controlled trials (\n                      <jats:styled-content style=\"fixed-case\">RCT<\/jats:styled-content>\n                      s) that evaluate adverse bone outcomes in older women using aromatase inhibitors (\n                      <jats:styled-content style=\"fixed-case\">AI<\/jats:styled-content>\n                      s) for early\u2010stage hormone receptor\u2013positive breast cancer.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Systematic review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>\n                      International\n                      <jats:styled-content style=\"fixed-case\">RCT<\/jats:styled-content>\n                      s referenced in\n                      <jats:styled-content style=\"fixed-case\">M<\/jats:styled-content>\n                      edline and\n                      <jats:styled-content style=\"fixed-case\">EMBASE<\/jats:styled-content>\n                      databases through\n                      <jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>\n                      ugust 1, 2011.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Postmenopausal women with early\u2010stage hormone receptor\u2013positive breast cancer receiving adjuvant endocrine therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements<\/jats:title>\n                    <jats:p>Fracture rates and changes in bone turnover markers and bone mineral density.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Eleven\n                      <jats:styled-content style=\"fixed-case\">RCT<\/jats:styled-content>\n                      s were identified. The majority of trials included women with a mean age in the 60s; and women aged 75 and older and 80 and older were excluded from two studies. Fracture rates ranged from 0.9% to 11%, with\n                      <jats:styled-content style=\"fixed-case\">AI<\/jats:styled-content>\n                      s having a 1.5 times higher risk than tamoxifen or placebo. Fracture data were not systematically collected in many of these trials. In a small subpopulation of women,\n                      <jats:styled-content style=\"fixed-case\">AI<\/jats:styled-content>\n                      s were associated with higher markers of bone turnover and lower bone density. The relationship between age and fracture was not described.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      <jats:styled-content style=\"fixed-case\">AI<\/jats:styled-content>\n                      s are associated with low bone density and high fracture risk in women with a mean age in their early 60s. There is a paucity of data describing the effect of baseline fracture risk factors, particularly age, and the longer\u2010term effects on bone health in older women. Future research is needed regarding baseline fracture risk, interventions, and long\u2010term effects on bone in this vulnerable population to inform management decisions to optimize\n                      <jats:styled-content style=\"fixed-case\">AI<\/jats:styled-content>\n                      duration and ensure quality of life after breast cancer.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1532-5415.2012.04107.x","type":"journal-article","created":{"date-parts":[[2012,9,17]],"date-time":"2012-09-17T12:41:25Z","timestamp":1347885685000},"page":"1761-1767","source":"Crossref","is-referenced-by-count":45,"title":["Systematic Review of Bone Health in Older Women Treated with Aromatase Inhibitors for Early\u2010Stage Breast Cancer"],"prefix":"10.1111","volume":"60","author":[{"given":"Taryn","family":"Becker","sequence":"first","affiliation":[{"name":"Department of Medicine University of Toronto Toronto Ontario Canada"},{"name":"Institute for Clinical Evaluative Sciences Toronto Ontario Canada"},{"name":"Women's College Research Institute Women's College Hospital Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine","family":"Lipscombe","sequence":"additional","affiliation":[{"name":"Department of Medicine University of Toronto Toronto Ontario Canada"},{"name":"Institute for Clinical Evaluative Sciences Toronto Ontario Canada"},{"name":"Women's College Research Institute Women's College Hospital Toronto Ontario Canada"},{"name":"Department of Health Policy Management and Evaluation University of Toronto Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Narod","sequence":"additional","affiliation":[{"name":"Department of Medicine University of Toronto Toronto Ontario Canada"},{"name":"Institute for Clinical Evaluative Sciences Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Simmons","sequence":"additional","affiliation":[{"name":"Department of Medicine University of Toronto Toronto Ontario Canada"},{"name":"St. Michael's Hospital Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey M.","family":"Anderson","sequence":"additional","affiliation":[{"name":"Institute for Clinical Evaluative Sciences Toronto Ontario Canada"},{"name":"Women's College Research Institute Women's College Hospital Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula A.","family":"Rochon","sequence":"additional","affiliation":[{"name":"Department of Medicine University of Toronto Toronto Ontario Canada"},{"name":"Institute for Clinical Evaluative Sciences Toronto Ontario Canada"},{"name":"Women's College Research Institute Women's College Hospital Toronto Ontario Canada"},{"name":"Department of Health Policy Management and Evaluation University of Toronto Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,9,17]]},"reference":[{"key":"e_1_2_6_2_1","volume-title":"Canadian Cancer Statistics 2011","author":"Canadian Cancer Society Steering Committee on Cancer Statistics","year":"2011"},{"key":"e_1_2_6_3_1","unstructured":"SEER cancer statistics review 1975\u20132009 (Vintage 2009 populations). National Cancer Institute Bethesda MD Based on November 2011 SEER Data Submission [on\u2010line]. Available athttp:\/\/seer.cancer.gov\/csr\/1975_2009_pops09\/Accessed June 28 2012."},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.0459"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2008.03.007"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09088-8"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052258"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djr242"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.4184"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/02841860802001467"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-152-6-201003160-00008"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.081720"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-007-0429-6"},{"issue":"10","key":"e_1_2_6_14_1","first-page":"S1","article-title":"2002 Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada","volume":"167","author":"Brown JP","year":"2002","journal-title":"Can Med Assoc J"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji250"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040331"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67059-6"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.08.8054"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.120"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-010-0888-x"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.0228"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2009.03.003"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn762"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2006.06.027"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.060508"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(07)70003-7"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.4882"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.0726"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp033"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(07)70385-6"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.100771"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-010-1493-x"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr017"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200724010-00003"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.G.00150"}],"container-title":["Journal of the American Geriatrics Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1532-5415.2012.04107.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1532-5415.2012.04107.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T11:41:52Z","timestamp":1762170112000},"score":1,"resource":{"primary":{"URL":"https:\/\/agsjournals.onlinelibrary.wiley.com\/doi\/10.1111\/j.1532-5415.2012.04107.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["10.1111\/j.1532-5415.2012.04107.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1532-5415.2012.04107.x","archive":["Portico"],"relation":{},"ISSN":["0002-8614","1532-5415"],"issn-type":[{"value":"0002-8614","type":"print"},{"value":"1532-5415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}